Raleigh, N.C.-based INC Research, a therapeutically focused CRO, has been accredited as an authorized provider of the International Association of Continuing Education and Training (IACET), strengthening its corporate training programs. INC says it is the only global CRO authorized provider offering Continuing Education Units (CEUs) that qualify under the ANSI/IACET standard.

IACET, a nonprofit association, is a standards-setting organization for continuing education and training. INC Research joins just 650 IACET authorized providers worldwide. After completing a rigorous application process, including a review by an IACET site visitor, INC Research demonstrated the appropriate standard of design, development, administration and evaluation of its training programs. Accreditation is for five years.

INC Research's training efforts are offered throughout all career stages, beginning with the hiring process. INC Research provides much of its training via INC College, a proprietary system of hundreds of readily accessible online and offline courses and workshops that can be accessed worldwide. Many of these training programs carry CEUs, all of which are now accredited by IACET.

Tammi Masters, R.N. CCRC, senior trainer at INC Research, was the only CRO and U.S. representative invited to participate on a global taskforce chartered to develop a set of best practice recommendations for effective training of all parties involved in pharmaceutical development and manufacturing. Masters helped draft new standardized drug development training practice guidelines, based on the initiative pioneered by the International Academy of Clinical Research (IAoCR), called GxP Training Guidelines.

IACET is the only standard-setting organization approved by the American National Standards Institute (ANSI) for continuing education and training.